Scholars Central

Short communicationPublished 2016

Novel Drug Development of the Next-Generation T790M Mutant Specific Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for the Treatment of Advanced Non-Small Cell Lung Cancer

Authors: Toshio Shimizu, Kazuhiko Nakagawa

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Lung cancer is a leading cause of cancer death worldwide. Lung cancer accounts for over 1 million mortalities annually and non-small cell lung cancer (NSCLC) accounts for almost 85% of all cases. Epidermal growth factor receptor (EGFR) mutations are found in approximately 10% and 30% of patients with NSCLC in North American/European and East Asian countries, respectively.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Biochemistry & Analytical Biochemistry.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalBiochemistry & Analytical Biochemistry
  • SubjectBiochemistry & Biotechnology
  • SubjectChemistry
  • BylineArticles whose byline prints “Toshio Shimizu”
  • BylineArticles whose byline prints “Kazuhiko Nakagawa”